Guided Therapeutics (GTHP) Preferred Shares (2013 - 2025)

Guided Therapeutics (GTHP) has 11 years of Preferred Shares data on file, last reported at $284000.0 in Q4 2025.

• For the quarter ending Q4 2025, Preferred Shares rose 67.06% year-over-year to $284000.0; the trailing twelve-month figure through Dec 2025 stood at $284000.0 (up 67.06% YoY), and the FY2025 full-year result was $284000.0, up 67.06% from the prior year.
• Preferred Shares advanced to $284000.0 in Q4 2025, from $61000.0 in the prior quarter.
• In the past five years, Preferred Shares ranged from a high of $892000.0 in Q3 2022 to a low of $32000.0 in Q1 2025.
• A 5-year average of $322894.7 and a median of $170000.0 in 2021 frame the typical range for Preferred Shares.
• Across the five-year window, Preferred Shares soared 424.71% in 2022 and slumped 96.16% in 2025, its largest moves.
• Tracing GTHP's Preferred Shares over 5 years: stood at $531000.0 in 2021, then sank by 80.23% to $105000.0 in 2022, then jumped by 61.9% to $170000.0 in 2023, then changed by 0.0% to $170000.0 in 2024, then soared by 67.06% to $284000.0 in 2025.
• Business Quant data shows GTHP's Preferred Shares at $284000.0 in Q4 2025, $61000.0 in Q2 2025, and $32000.0 in Q1 2025.